Zydus Lifesciences told exchanges that the US FDA inspection of its Moraiya plant ended on October 13 with five observations. The inspection ran from 5...
The US weighs a 90-day diesel export ban, alarming Europe, while India faces a potential 100% tariff threat over Russian oil purchases. The plan would...
Biocon surges to Rs 429 on Monday after the company launched its Eylea biosimilar Yesafili in the United States ophthalmology market. Yesafili is Biocon’s biosimilar...